ADVIL PM LIQUI-GELS OTC
Generic Name and Formulations:
Ibuprofen (solubilized) 200mg, diphenhydramine HCl 25mg.
Pfizer Consumer Healthcare
Indications for ADVIL PM LIQUI-GELS:
Relief of occasional sleeplessness when associated with minor aches and pains.
2 caplets or liqui-gels at bedtime. Max 2 caplets or liqui-gels/24hrs.
<12yrs: not recommended.
Aspirin allergy. Unless sufficient time for a full night's sleep. Immediately before or after cardiac surgery. Sleeplessness without pain. Concomitant with other diphenhydramine-containing products (including topicals).
Increased risk of severe stomach bleeding (esp. ≥60yrs old). History of GI disorders (eg, heartburn, bleeding ulcers). Respiratory disorders (eg, emphysema, bronchitis). Increased risk of heart attack or failure, and stroke. Hypertension. Heart disease. Recent stroke. Liver cirrhosis. Renal disease. Asthma. Glaucoma. GI or urinary obstruction. Reevaluate if pain persists or worsens after >10 days or sleeplessness persists continuously >2 weeks. Elderly. Pregnancy (avoid during 3rd trimester). Nursing mothers.
NSAID + hypnotic (anticholinergic).
Avoid aspirin or other pain relievers. Increased risk of GI bleed with anticoagulants, corticosteroids, other OTC or Rx NSAID-containing products (eg, ibuprofen, naproxen, others), ≥3 alcoholic drinks/day, or prolonged use. Caution with diuretics. Additive effects with other antihistamines, anticholinergics, sedatives, tranquilizers, or any other sleep-aid.
Drowsiness, GI upset/bleed, rash, symptoms of heart problems or stroke (eg, trouble breathing, feel faint, slurred speech), redness, swelling, allergic reactions; discontinue if occur.
Caplets—20, 40, 80, 120 (orig or EZ open); Liqui-Gels—20, 40, 80
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Cochrane Data Release and the Case for "Open Science"
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Characteristics of Acquired Partial Lipodystrophy With Metabolic Abnormalities
- Poor Glycemic Control Associated With Higher Risk for Dementia in Older Adults With T1D
- Shift Seen From EDs to Urgent Care for Low-Acuity, Acute Care